Tisento
United States · Founded 2023 · $81.0M raised
- Employees
- 1–10
- Founded
- 2023
- Business Model
- B2B
- Website
- tisentotherapeutics.com
- Total Funding
- $81.0M
- Last Round
- Series AJul 2023
- Rounds
- 1
About
Clinical-stage biotech developing sGC stimulator therapeutics for neurological and cardiovascular diseases.
Summary
Tisento is a Biotech company based in United States, founded in 2023. It has raised $81.0M in total across 1 round, most recently a Series A round in Jul 2023. Investors include Venrock, Polaris Partners and Sanofi Ventures.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Jul 2023
Investors
Similar Companies
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Global contract development and manufacturing organization (CDMO) focused exclusively on sterile ...
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.